admin | Private Eye Surgery

FDA Approve new drug

Jul 31, 2020 | News, Pinned blog

2.A new drug BEOVU (brolucizumab) has been approved by the FDA for the treatment of wet macular degeneration. Wet age related macular degeneration is the main cause of blind registration in UK. BEOVU is manufactured by Novartis and is an anti-vascular endothelial...

Working with British Medical Association (BMA)

Jul 31, 2020 | News and opinion of our consultants

Private Eye Surgery consultant Mr Aftab has been working with British Medical Association (BMA) to raise awareness nationally of the need to take practical steps to protect all vulnerable health care workers who are at an increased risk of having an adverse outcome...

New study from University of Virginia

Mar 31, 2020 | News

A new study from University of Virginia School of Medicine found that exercise can prevent or slow down the progression of macular degeneration and may also benefit other causes of vision loss, such as diabetic retinopathy. Exercise can slow or prevent vision loss,...

COVID-19 had had a disproportionate effect on ethnic minorities

Jul 16, 2019 | News

COVID-19 had had a disproportionate effect on ethnic minorities with significantly high death rate as compared to other ethnicities. More than 94% of the doctors who sadly lost their lives due to COVID-19 infection were from ethnic minorities. Private Eye Surgery...